My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

    Ogawa N, List JF, Habener JF, Maki T.

    Diabetes. 2004 Jul;53(7):1700-5.PMID: 15220193 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

    Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC.

    Endocrinology. 2007 Nov;148(11):5136-44. Epub 2007 Aug 2.PMID: 17673522 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.

    Maki T, Ichikawa T, Blanco R, Porter J.

    Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3434-8.PMID: 1565635 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.

    Ogawa N, Minamimura K, Kodaka T, Maki T.

    J Autoimmun. 2006 Jun;26(4):225-31. Epub 2006 May 18.PMID: 16713179 [PubMed - indexed for MEDLINE]Related articles

    6.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    7.

    Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.

    Mottram PL, Murray-Segal LJ, Han W, Maguire J, Stein-Oakley AN.

    Transpl Immunol. 2002 Jun;10(1):63-72.PMID: 12182467 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A.

    Diabetes. 2008 Dec;57(12):3281-8. Epub 2008 Oct 3.PMID: 18835930 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice.

    Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A.

    Diabetes. 2005 Sep;54(9):2596-601.PMID: 16123347 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.

    Reddy S, Cheung CC, Chai RC, Rodrigues JA.

    Ann N Y Acad Sci. 2008 Dec;1150:171-6.PMID: 19120289 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.

    Yang Z, Chen M, Carter JD, Nunemaker CS, Garmey JC, Kimble SD, Nadler JL.

    Biochem Biophys Res Commun. 2006 Jun 9;344(3):1017-22. Epub 2006 Apr 5.PMID: 16643856 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

    Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL.

    J Clin Invest. 2001 Jul;108(1):63-72.PMID: 11435458 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.

    Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST.

    Surgery. 2006 Aug;140(2):281-8.PMID: 16904981 [PubMed - indexed for MEDLINE]Related articles

    14.

    The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.

    Yang ZD, Chen M, Wu R, McDuffie M, Nadler JL.

    Diabetologia. 2002 Sep;45(9):1307-14. Epub 2002 Aug 1.PMID: 12242464 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

    Chatenoud L, Thervet E, Primo J, Bach JF.

    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-7.PMID: 8278351 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.

    Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA.

    Diabetes. 2009 Oct;58(10):2277-84. Epub 2009 Jul 23.PMID: 19628781 [PubMed - indexed for MEDLINE]Related articles

    17.

    Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency.

    Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ.

    Ann N Y Acad Sci. 2008 Dec;1150:152-6.PMID: 19120286 [PubMed - indexed for MEDLINE]Related articles

    18.

    Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes.

    Sharma A, Sörenby A, Wernerson A, Efendic S, Kumagai-Braesch M, Tibell A.

    Diabetologia. 2006 Jun;49(6):1247-53. Epub 2006 Apr 12.PMID: 16609877 [PubMed - indexed for MEDLINE]Related articles

    19.

    Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.

    Juang JH, Kuo CH, Wu CH, Juang C.

    Cell Transplant. 2008;17(6):641-7.PMID: 18819252 [PubMed - indexed for MEDLINE]Related articles

    20.

    Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.

    Begum S, Chen W, Herold KC, Papaioannou VE.

    Endocrinology. 2009 Oct;150(10):4512-20. Epub 2009 Jul 9.PMID: 19589867 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity